CD274 and neoplasm: These data provide unequivocal evidence that activated T cells play a central role in vascular remodeling and that anti-tumor therapy with checkpoint inhibitors blocking the PD-1-PD-L1 axis threatens the immune protection of the aorta and its major branches (83).